Volume 15, Number 4—April 2009
Skin and Soft Tissue Infections (Patera Foot) in Immigrants, Spain
An unusual skin and soft tissue infection of the lower limbs has been observed in immigrants from sub-Saharan Africa who cross the Atlantic Ocean crowded on small fishing boats (pateras). Response to conventional treatment is usually poor. Extreme extrinsic factors (including new pathogens) may contribute to the etiology of the infection and its pathogenesis.
Immigration is increasing from poor-resourced countries into Spain and other European countries (1). From the coasts of Mauritania and Morocco, each year ≈10,000 African people try to reach the coasts of the Canary Islands or the southern Iberian Peninsula by sea, aboard small boats (called pateras) (2). These boats, normally used for fishing, have capacity for only a few persons but these sea crossings are overcrowded with 40–50 persons and with minimal water and food provisions. The journey lasts several days, during which travelers are exposed to extreme conditions, including cold weather; deficient hygiene; prolonged sitting in the same position; and prolonged immersion of their feet in sea water possibly contaminated by traces of feces, urine, decaying food, or fuel–water emulsions. On arrival, many need medical care for hypothermia and dehydration. However, despite efforts of authorities to prevent humanitarian disaster, frequently these boats sink, and bodies are later found along the coast of the Canary Islands.
Among the varied medical problems affecting these young, previously healthy immigrants are unexpectedly high numbers of severe skin and soft tissue infections (SSTIs), especially those involving the feet and legs. Clinical characteristics of these SSTIs were unfamiliar to our department, even though our unit collaborates directly with vascular surgeons, endocrinologists, and dermatologists to manage diabetes-related foot infections. The clinical picture comprises a painful cellulitis with minimal or imperceptible port of entry, deep abscesses, and tissue necrosis. Response to surgical debridement and broad-spectrum antimicrobial drugs is frequently poor, making amputation necessary in many cases. Here we describe the epidemiology, clinical features, microbiology, treatment, and outcome of 7 patients affected with severe SSTIs of the foot and leg and discuss the pathogenic role of Shewanella algae as an etiologic agent in this syndrome.
The 7 patients were treated at our Unit of Infectious Diseases and Tropical Medicine at the Hospital Universitario Insular of Las Palmas (Gran Canaria Island, Canary Islands, Spain). We defined the condition we call “patera foot” as all of the following: 1) acute SSTI involving the feet or legs, 2) direct relation of the infection to sea journey by overcrowded patera under extreme conditions, and 3) good health status before travel. For this report, we excluded patients with diabetes, chronic arterial or venous leg disease, edema, or any other predisposing conditions.
We performed the following basic interventions for all patients: registry of epidemiologic data; complete clinical history and physical examination; blood extraction for routine tests; blood cultures (if fever); cleaning and debridement of the affected area (if indicated by the vascular surgery team); and acquisition of cultures from the affected area by syringe (if abscess), skin punch (if cellulitis only), or deep infected tissue (if surgical debridement). Plastic surgery was performed when indicated. Amputation was carried out only after every effort was made to preserve the affected foot or leg.
All 7 patients whose conditions met the classification criteria were young, black, sub-Saharan men (Table). In all patients, we ruled out a defined immunodeficiency, specifically HIV infection; use of immunosuppressive agents; and indirect data suggesting primary immunodeficiency (lymphopenia or immunoglobulin deficiency). Organisms isolated from local specimens were gram-negative bacteria in all microbiologically positive cases. Four patients underwent amputation, including 1 transtibial and 1 transmetatarsal.
Patient 7, a 21-year-old man, was admitted to the intensive care unit because of shock secondary to severe SSTI and intense dehydration with acute renal failure and rhabdomyolysis. Bilateral painful enlargement of his lower extremities was evident, with disseminated round ulcers and serohemorrhagic, confluent blisters. The ulcers were covered with a fibrinoid, purulent exudate (Figure, panel A). After blood and skin samples were collected for culture, the patient began taking meropenem and linezolid . Skin samples grew gram-negative rods, initially identified as S. putrefaciens by using the API 20E system (bioMérieux, Marcy l’Etoile, France). By using experimental work (3–5) that allows differentiation between Shewanella species, we identified the organism as S. algae on the basis of its capacity to grow at 42ºC in 6.5% NaCl and to produce beta-hemolysis. The organism displayed in vitro susceptibility to ceftazidime, meropenem, piperacilin/tazobactam, ciprofloxacin, aminoglycosides, trimethoprim/sulfamethoxazole and aztreonam but resistance to amoxicilin/clavulamate, cefotaxime, and, notably, to imipenem (because S. algae is sensitive to other carbapenems i.e., meropenem). Four days after the patient was admitted to our unit, a large fluctuant area appeared on the dorsum of his left foot; drainage from the area consisted of a grossly purulent, foul-smelling material. Extensive debridement was necessary to control infection (Figure, panel B); 1 month later, a skin allograft was implanted (Figure, panel C). The patient was discharged, asymptomatic, after 70 days of hospitalization.
During sea crossing by patera, immigrants are exposed to extreme extrinsic conditions, such as cold weather and deficient hygienic conditions. Intrinsic factors, such as limited skin compliance related to young age and possibly race, may play additional roles in the pathogenesis of this syndrome. Black race may be an intrinsic factor because, to our knowledge, immigrants of other ethnic origin (Magreb countries) have not developed this syndrome.
The presence of gram-negative bacteria in all case-patients, especially S. algae in 1, instead of gram-positive cocci, indicates a source of infection related to water and illustrates the specific pathogenesis of this syndrome. Shewanella spp. are ubiquitous gram-negative bacteria; possible reservoirs include all types of water, oil emulsions, petroleum brines, protein-rich foods, and soil (5–7). Two Shewanella species, S. algae and S. putrefaciens, have been found in clinical specimens. Because automated systems are unable to distinguish between the 2 species, a number of infections attributed to S. putrefaciens probably correspond to S. algae (4). S. algae is considered a rare opportunistic pathogen for humans, frequently involving immunocompromised hosts (6,8,9), and are usually part of a polymicrobial infection (6,10,11), which may mask its clinical importance. The presence of chronic leg ulcers in the context of peripheral vascular disease occurs commonly in adults with S. algae SSTI (6,10,12,13), and the affinity of S. algae for necrotic or ischemic tissues has been well described (12,14,15).
The following sequence may explain why these young, previously healthy men developed such aggressive SSTIs. We speculate that specific etiologic agents (mainly GNB, including S. algae) present in densely contaminated water enter through macerated skin, then reach deep tissues that have been submitted to subacute ischemia from overpressure and deficient venous drainage, both related to forced, prolonged sitting. The ensuing inner inflammation, expanding against a young skin with limited compliance, further aggravates the ischemia and leads to necrosis, probably by a compartmental-like mechanism.
These cases appear to represent a new syndrome, with specific etiology, pathogenesis, clinical features, and response to treatment. GNB, including S. algae, are involved, and an ischemic mechanism may be crucial in the development of these destructive infections. The initial election of empirical therapy, always covering those pathogens, and early surgical evaluation are crucial in preventing major disability in these young people.
Mr Ternavasio-de la Vega is training in Internal Medicine in Hospital Universitario of Salamanca and pursuing a PhD degree at University of Salamanca, Spain. His main research interests include emerging infectious diseases.
We are grateful to Manuel Diaz, Purificación Sánchez, and Juan Carlos Durán for the clinical management of patients.
- Pardo J, Carranza C, Muro A, Angel-Moreno A, Martin AM, Martin T, Helminth-related eosinophilia in African immigrants, Gran Canaria. Emerg Infect Dis. 2006;12:1587–9.
- El número de inmigrantes llegados a Canarias desciende un 28% [cited 2009 Feb 9]. Available from http://www.elpais.com/articulo/espana/numero/inmigrantes/llegados/Canarias/desciende/28/elpepuesp/20081230elpepunac_7/Tes
- Khashe S, Janda JM. Biochemical and pathogenic properties of Shewanella alga and Shewanella putrefaciens. J Clin Microbiol. 1998;36:783–7.
- Hayashi T, Hashimoto Y, Ezaki T, Hamasaki K, Ohwada K, Isolation and characterization of Shewanella alga from human clinical specimens and emendation of the description of S. alga Simidu et al. 1990, 335. Int J Syst Bacteriol. 1992;42:628–34.Nozue H
- Vogel BF, Jorgensen K, Christensen H, Olsen JE, Gram L. Differentiation of Shewanella putrefaciens and Shewanella alga on the basis of whole-cell protein profiles, ribotyping, phenotypic characterization, and 16S rRNA gene sequence analysis. Appl Environ Microbiol. 1997;63:2189–99.
- Chen YS, Liu YC, Yen MY, Wang JH, Wang JH, Wann SR, Skin and soft-tissue manifestations of Shewanella putrefaciens infection. Clin Infect Dis. 1997;25:225–9.
- Martin-Gil J, Ramos-Sanchez MC, Martin-Gil FJ. Shewanella putrefaciens in a fuel-in-water emulsion from the Prestige oil spill. Antonie Van Leeuwenhoek. 2004;86:283–5.
- Pagani L, Lang A, Vedovelli C, Moling O, Rimenti G, Pristera R, Soft tissue infection and bacteremia caused by Shewanella putrefaciens. J Clin Microbiol. 2003;41:2240–1.
- Iwata M, Tateda K, Matsumoto T, Furuya N, Mizuiri S, Yamaguchi K. Primary Shewanella alga septicemia in a patient on hemodialysis. J Clin Microbiol. 1999;37:2104–5.
- Aspiroz C, Navarro C, Aguilar E, Rodriguez-Andres M. Bacteremia in an obese patient with cellulitis and chronic ulceration in the lower extremity. Enferm Infecc Microbiol Clin. 2004;22:363–4.
- Dhawan B, Chaudhry R, Mishra BM, Agarwal R. Isolation of Shewanella putrefaciens from a rheumatic heart disease patient with infective endocarditis. J Clin Microbiol. 1998;36:2394.
- Dominguez H, Vogel BF, Gram L, Hoffmann S, Schaebel S. Shewanella alga bacteremia in two patients with lower leg ulcers. Clin Infect Dis. 1996;22:1036–9.
- Paccalin M, Grollier G, le Moal G, Rayeh F, Camiade C. Rupture of a primary aortic aneurysm infected with Shewanella alga. Scand J Infect Dis. 2001;33:774–5.
- Debois J, Degreef H, Vandepitte J, Spaepen J. Pseudomonas putrefaciens as a cause of infection in humans. J Clin Pathol. 1975;28:993–6.
- Botelho-Nevers E, Gouriet F, Rovery C, Paris P, Roux V, Raoult D, First case of osteomyelitis due to Shewanella algae. J Clin Microbiol. 2005;43:5388–90.
- Figure. Progression of infection (patera foot) in case-patient 7, a previously healthy 21-year-old immigrant from sub-Saharan Africa who reached Spain by sea crossing on a small boat (patera). A) Initial severe...
- Table. Clinical characteristics of 7 black male immigrants to Spain who developed severe skin and soft tissue infections (patera foot) following sea crossing from Africa on small boats (pateras)
Suggested citation for this article: Ternavasio-de la Vega H-G, Ángel-Moreno A, Hernández-Cabrera M, Pisos-Álamo E, Bolaños-Rivero M, Carranza-Rodriguez C, et al. Skin and soft tissue infections (patera foot) in immigrants, Spain. Emerg Infect Dis [serial on the Internet]. 2009 Apr [date cited]. Available from http://wwwnc.cdc.gov/eid/article/15/4/08-1457
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
- Page created: December 10, 2010
- Page last updated: December 10, 2010
- Page last reviewed: December 10, 2010
- Centers for Disease Control and Prevention,
National Center for Emerging and Zoonotic Infectious Diseases (NCEZID)
Office of the Director (OD)